Home > De Brauw news and matters > Patheon to be acquired by Thermo Fisher Scientific in a USD 7.2 billion recommended tender offer
Thermo Fisher Scientific will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for USD 35.00 per share in cash. The transaction represents a purchase price of approximately USD 7.2 billion, which includes the assumption of approximately USD 2.0 billion of net debt.
Team: Paul Cronheim, Tijmen Klein Bronsvoort and Rick van ‘t Wout.
12 June 2020
10 March 2020
4 March 2020
31 December 2019
24 December 2019
29 November 2019
21 November 2019
15 November 2019
11 November 2019
29 October 2019
De Brauw Blackstone Westbroek
Claude Debussylaan 80
1082 MD Amsterdam
The Netherlands
P.O. Box 75084
1070 AB Amsterdam
The Netherlands